The Food and Drug Administration (FDA) established a new piece of compliance legislation in 1997 that established for the first time, conditions that must be met in order to substitute electronic records for paper records. 21 CFR Part 11 (or Part 11 for short), describes controls that must be in place to ensure the integrity of systems operations and the information stored on those systems.
This paper provides a discussion of those sections of Part 11, where thin client technology can be applied to satisfy those compliance issues, and how a move to thin client technology can make good business sense as well.
Thin client technology requires a paradigm shift back to the early days of centralized computing. Today a typical application might include one or several computers near the process that each have their own operating system, HMI software package, (including hardware or software license key and security access), data manipulation and storage capability and maybe even reporting capability. The system architecture implemented in this fashion can be referred to as "thick client" or distributed control. Communication back to a network server may be for data collection only.
This thick client architecture described above, presents several challenges for those industries required to meet Part 11 compliance.
By replacing the thick clients with thin clients, many of the challenges presented above become much easier to solve. Thin client technology takes advantage of Microsoft's Terminal Services feature of Windows 2000 Server. The thick clients can be replaced with terminals without hard drives, floppy or CD ROM drives and a relatively small amount of RAM. If budgets require, existing clients could still be used even if they are running an older Windows OS such as Windows 3.XX/95/98.
In the thin client architecture, the validation process becomes much easier. Since the operating system and application software is loaded on the server(s), the whole process of software installation, configuration and verification is eliminated for the terminals. Further, if a terminal dies, instead of being down for hours or days while hardware and software is re-installed, configured and validated, it could be as simple as plugging in a new terminal and turning it on.
Future upgrading of operating system, HMI software, adding service packs, etc is performed on the server(s) only. The terminals will reap the immediate benefit of the upgrades without making any changes to its hardware or software. And by eliminating hard drives, floppy and CD ROM drives from terminals, hacking into the system and introducing viruses into the system becomes much more difficult if not impossible.
Since data is no longer transferred between terminals and the server, the effort required to verify the transfer and validate the data is eliminated. Since data is no longer stored on local hard drives, the threat of data loss from client hardware failure is eliminated. Since data is manipulated and stored only on the server(s), in friendly environments, redundancy, disaster recovery, and protection from loss of power, become much easier to implement.
In summary, thin client technology provides many advantages to FDA regulated industries that must comply with 21 CFR Part 11. They are:
For additional information about the FDA rule 21 CFR Part 11, visit the following website:
Mr. Bruce Lauderman, P.E., is Vice President of Performance Automation and Controls, LLC, a company that provides integration and consulting services to many customers, including the food and pharmaceutical industries. PAC specializes in helping pharmaceutical companies comply with 21 CFR Part 11, in both gap assessment and remediation. For information on PAC, visit the company's website at:
You can contact Mr. Lauderman directly as follows:
Bruce Lauderman, P.E.
(269) 217-8500
For more information on ACP Industrial Thin Client computers, please visit our web site at http://www.thinmanager.com
To sign up for the E-mail newsletter go here: ACP newsletter signup
For an archive of past newsletter articles go to: ACP Newsletter Archive